PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SM vs. ABBV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between SM and ABBV is 0.15, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

SM vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in SM Energy Company (SM) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

-15.00%-10.00%-5.00%0.00%5.00%SeptemberOctoberNovemberDecember2025February
-12.20%
1.61%
SM
ABBV

Key characteristics

Sharpe Ratio

SM:

0.12

ABBV:

0.67

Sortino Ratio

SM:

0.42

ABBV:

1.00

Omega Ratio

SM:

1.05

ABBV:

1.15

Calmar Ratio

SM:

0.08

ABBV:

0.87

Martin Ratio

SM:

0.29

ABBV:

2.02

Ulcer Index

SM:

16.02%

ABBV:

8.21%

Daily Std Dev

SM:

38.11%

ABBV:

24.77%

Max Drawdown

SM:

-98.85%

ABBV:

-45.09%

Current Drawdown

SM:

-54.42%

ABBV:

-2.83%

Fundamentals

Market Cap

SM:

$4.42B

ABBV:

$346.45B

EPS

SM:

$7.14

ABBV:

$2.39

PE Ratio

SM:

5.41

ABBV:

82.11

PEG Ratio

SM:

0.57

ABBV:

2.63

Total Revenue (TTM)

SM:

$1.84B

ABBV:

$56.33B

Gross Profit (TTM)

SM:

$831.21M

ABBV:

$41.47B

EBITDA (TTM)

SM:

$1.37B

ABBV:

$17.62B

Returns By Period

In the year-to-date period, SM achieves a 0.12% return, which is significantly lower than ABBV's 11.48% return. Over the past 10 years, SM has underperformed ABBV with an annualized return of -1.20%, while ABBV has yielded a comparatively higher 17.16% annualized return.


SM

YTD

0.12%

1M

-10.19%

6M

-11.71%

1Y

-0.62%

5Y*

35.97%

10Y*

-1.20%

ABBV

YTD

11.48%

1M

14.39%

6M

1.81%

1Y

14.60%

5Y*

20.87%

10Y*

17.16%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SM vs. ABBV — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SM
The Risk-Adjusted Performance Rank of SM is 4646
Overall Rank
The Sharpe Ratio Rank of SM is 5050
Sharpe Ratio Rank
The Sortino Ratio Rank of SM is 4242
Sortino Ratio Rank
The Omega Ratio Rank of SM is 4242
Omega Ratio Rank
The Calmar Ratio Rank of SM is 4949
Calmar Ratio Rank
The Martin Ratio Rank of SM is 4848
Martin Ratio Rank

ABBV
The Risk-Adjusted Performance Rank of ABBV is 6565
Overall Rank
The Sharpe Ratio Rank of ABBV is 6767
Sharpe Ratio Rank
The Sortino Ratio Rank of ABBV is 5757
Sortino Ratio Rank
The Omega Ratio Rank of ABBV is 6161
Omega Ratio Rank
The Calmar Ratio Rank of ABBV is 7575
Calmar Ratio Rank
The Martin Ratio Rank of ABBV is 6565
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SM vs. ABBV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for SM Energy Company (SM) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for SM, currently valued at 0.12, compared to the broader market-2.000.002.004.000.120.67
The chart of Sortino ratio for SM, currently valued at 0.42, compared to the broader market-6.00-4.00-2.000.002.004.006.000.421.00
The chart of Omega ratio for SM, currently valued at 1.05, compared to the broader market0.501.001.502.001.051.15
The chart of Calmar ratio for SM, currently valued at 0.08, compared to the broader market0.002.004.006.000.080.87
The chart of Martin ratio for SM, currently valued at 0.29, compared to the broader market0.0010.0020.0030.000.292.02
SM
ABBV

The current SM Sharpe Ratio is 0.12, which is lower than the ABBV Sharpe Ratio of 0.67. The chart below compares the historical Sharpe Ratios of SM and ABBV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.002.50SeptemberOctoberNovemberDecember2025February
0.12
0.67
SM
ABBV

Dividends

SM vs. ABBV - Dividend Comparison

SM's dividend yield for the trailing twelve months is around 1.97%, less than ABBV's 3.21% yield.


TTM20242023202220212020201920182017201620152014
SM
SM Energy Company
1.97%1.91%1.55%0.46%0.07%0.33%0.89%0.65%0.45%0.29%0.51%0.26%
ABBV
AbbVie Inc.
3.21%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%2.54%

Drawdowns

SM vs. ABBV - Drawdown Comparison

The maximum SM drawdown since its inception was -98.85%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for SM and ABBV. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-54.42%
-2.83%
SM
ABBV

Volatility

SM vs. ABBV - Volatility Comparison

SM Energy Company (SM) has a higher volatility of 10.41% compared to AbbVie Inc. (ABBV) at 7.58%. This indicates that SM's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%SeptemberOctoberNovemberDecember2025February
10.41%
7.58%
SM
ABBV

Financials

SM vs. ABBV - Financials Comparison

This section allows you to compare key financial metrics between SM Energy Company and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab